Craig C. Hopkinson net worth and biography

Craig Hopkinson Biography and Net Worth

EVP of Alkermes

Dr. Craig C. Hopkinson M.D. serves as Executive Vice President, Research and Development and Chief Medical Officer of the Company. Prior to assuming his current positions, Dr. Hopkinson was our Chief Medical Officer, and Senior Vice President of Medicines Development and Medical Affairs from February 2018 to January 2020, and our Chief Medical Officer and Senior Vice President of Clinical Development and Medical Affairs from May 2017 to February 2018. Prior to joining the Company, Dr. Hopkinson served as Senior Vice President of Clinical Development and Head of Global Medical Affairs at Vertex Pharmaceuticals Incorporated from July 2014 until May 2017. Prior to that, Dr. Hopkinson held various executive management positions at Eisai Pharmaceuticals, including President Eisai Value Maximization Systems from January 2013 to July 2014 and President and Chief Medical Officer of the Frontier Product Creation Unit from October 2011 to December 2012. Dr. Hopkinson has extensive experience in research and development, medical affairs, and interactions with the FDA.

What is Craig C. Hopkinson's net worth?: The estimated net worth of Craig C. Hopkinson is at least $2.32 million as of November 11th, 2024. Dr. Hopkinson owns 83,300 shares of Alkermes stock worth more than $2,324,903 as of November 21st. This net worth approximation does not reflect any other investments that Dr. Hopkinson may own. Additionally, Dr. Hopkinson receives an annual salary of $1,240,000.00 as EVP at Alkermes. Learn More about Craig C. Hopkinson's net worth.
How old is Craig C. Hopkinson?: Dr. Hopkinson is currently 56 years old. There are 6 older executives and no younger executives at Alkermes. The oldest executive at Alkermes is Dr. Floyd E. Bloom M.D., Founder, who is 87 years old. Learn More on Craig C. Hopkinson's age.
What is Craig C. Hopkinson's salary?: As the EVP of Alkermes plc, Dr. Hopkinson earns $1,240,000.00 per year. The highest earning executive at Alkermes is Mr. Richard F. Pops, Chairman & CEO, who commands a salary of $2,610,000.00 per year. Learn More on Craig C. Hopkinson's salary.
How do I contact Craig C. Hopkinson?: The corporate mailing address for Dr. Hopkinson and other Alkermes executives is 1 BURLINGTON ROAD CONNAUGHT HOUSE, DUBLIN L2, DUBLIN 4. Alkermes can also be reached via phone at (531) 772-8000 and via email at [email protected]. Learn More on Craig C. Hopkinson's contact information.
Has Craig C. Hopkinson been buying or selling shares of Alkermes?: Craig C. Hopkinson has not been actively trading shares of Alkermes over the course of the past ninety days. Learn More on Craig C. Hopkinson's trading history.
Who are Alkermes' active insiders?: Alkermes' insider roster includes Emily Alva (Director), David Anstice (Director), Iain Brown (CFO), Shane Cooke (Director), Wendy Dixon (Director), David Gaffin (SVP), Craig Hopkinson (EVP), Blair Jackson (COO), Michael Landine (SVP), Cato Laurencin (Director), Christian Nichols (SVP), Richard Pops (CEO), and Nancy Wysenski (Director). Learn More on Alkermes' active insiders.
Are insiders buying or selling shares of Alkermes?: During the last year, insiders at the sold shares 3 times. They sold a total of 79,884 shares worth more than $2,376,526.01. The most recent insider tranaction occured on November, 11th when EVP Craig C Hopkinson sold 58,996 shares worth more than $1,774,599.68. Insiders at Alkermes own 4.9% of the company. Learn More about insider trades at Alkermes.
Information on this page was last updated on 11/11/2024.

Craig C. Hopkinson Insider Trading History at Alkermes

Craig C. Hopkinson Buying and Selling Activity at Alkermes

Alkermes Company Overview

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Today's Range

Now: $27.91

$27.37

$28.29

50 Day Range

MA: $27.84

$25.70

$30.08

2 Week Range

Now: $27.91

$22.22

$32.88

Volume

1,694,996 shs

Average Volume

1,954,297 shs

Market Capitalization

$4.52 billion

P/E Ratio

14.31

Dividend Yield

N/A

Beta

0.47

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

Craig Hopkinson Biography and Net Worth

What is Craig C. Hopkinson's net worth?

How old is Craig C. Hopkinson?

What is Craig C. Hopkinson's salary?

How do I contact Craig C. Hopkinson?

Has Craig C. Hopkinson been buying or selling shares of Alkermes?

Who are Alkermes' active insiders?

Are insiders buying or selling shares of Alkermes?